Children aged 6 months to 4 years with underlying medical conditions should be offered the jab according to the JCVI as they are seven times more likely to be admitted to paediatric intensive care...
The latest studies of interest to primary care clinicians rounded up by Mark Greener
Mark Greener looks into the latest evidence on catheterisation.
Sarah Kipps looks at what nurses need to know when advising young people on sexual health
The NHS has today struck a deal with AstraZeneca thus allowing NICE to make a recommendation of the drug, olaparib for treatment of BRCA-mutated breast and prostate cancers.
The children aged between 3 and 18 years were the first in the world to receive curative anti-viral tablets that has a treatment success rate of 99%.
The new prescription pre-payment certificate (PPC) launched on the 1st April and has allowed women to access a year’s worth of HRT for just £19.30, saving them hundreds of pounds.
Approximately five million people will be eligible for the jab, including the over 75s, those with weakened immune systems and older adult care home residents.
Testing will continue to focus on those at the highest risk
The immunotherapy drug pembrolizumab is expected to help around 400 patients whose disease hasn’t responded to other treatments
Health think tanks the Nuffield Trust and The Kings Fund analysed the British Social Attitudes (BSA) survey and found that overall satisfaction with the heath service stands at 29%.
RCN members have until 9am on 14 April to cast their vote on whether to accept or reject the offer via the RCN website.
We need to give more thought to how environmentally sustainable the NHS is. Wearing overshoes does not stop us from having a carbon footprint
BJN provides nurses with an evidence base for clinical practice and a platform for professional development. It shares the information and advice that is key to unlocking your full potential.
Clinical expertise
Peer-reviewed research
Best practice guidance
CPD support
